clinical trials for glp-1 obesity meds actively recruiting From Post to Prescription: How is Social Media shaping the conversation on and on Pharmacotherapy Obesity? What is the pipeline for

Diabetic gastroparesis (DGp) is a component of autonomic neuropathy resulting from long-standing poorly controlled type 1 and type 2 diabetes

Part II: The Gray Market of Compounded GLP-1 Injections A Dangerous Alternative The sterile compounding pharmacy you choose is important

#STATBreakthrough

The rise of GLP-1 medicationssuch as Ozempic and Wegovyis rapidly transforming employer-sponsored health insurance.

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

Each pack contains 30 patches for a full month of use